In the United States, three monoclonal antibody therapies targeting SARS-CoV-2 are available for the treatment of non-ho
Posted: Wed Apr 20, 2022 8:31 am
In the United States, three monoclonal antibody therapies
targeting SARS-CoV-2 are available for the treatment of
non-hospitalized adults (≥18 years of age) and children (≥12 years
of age weighing at least 40 kg) with mild to moderate COVID-19 and
specific risk factors for severe disease. This monclonal antibody
therapy refers to the 3 vaccines (Moderna, Pfizer and J&J)
currently available in the USA.
True or false
targeting SARS-CoV-2 are available for the treatment of
non-hospitalized adults (≥18 years of age) and children (≥12 years
of age weighing at least 40 kg) with mild to moderate COVID-19 and
specific risk factors for severe disease. This monclonal antibody
therapy refers to the 3 vaccines (Moderna, Pfizer and J&J)
currently available in the USA.
True or false